Tennessee Oncology is home to one of the leading clinical trial networks in the country. We offer a broad menu of trial opportunities in every phase of treatment. Use the search below to discover and learn more about our clinical trials:
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/​Refractory Diffuse Large B-Cell Lymphoma
Condition: Large B-Cell Lymphoma
TO Study: LYM24024
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC (PACIFIC-8)
Condition: Non-small Cell Lung Cancer
TO Study: LUN25073
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations
Condition: Non-small Cell Lung Cancer
TO Study: LUN24045
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer (NeoCOAST-2)
Condition: Non-small Cell Lung Cancer
TO Study: LUN 494
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) (KLK2-comPAS)
Condition: Prostate Cancer
TO Study: GU24014
Clinic:
Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
TO Study: CLL24007
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)
Condition: Melanoma
TO Study: SKN25006
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) (SUCCESSOR-2)
Condition: Multiple Myeloma
TO Study: MM24009
Clinic:
Elliston Place Plaza, Murfreesboro, Smyrna, Chattanooga Downtown, Med Park 2, Memorial
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer (SUNRAY-02)
Condition:
TO Study: LUN24050
Clinic:
Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
Study of Olverembatinib (HQP1351) in Patients With CP-CML (POLARIS-2)
Condition: Chronic Myeloid Leukemia
TO Study: CML24002
Clinic:
Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma
Condition: Follicular Lymphoma
TO Study: LYM24017
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR
Condition: Breast Cancer
TO Study: BRE24016
Clinic:
Elliston Place Plaza, Lebanon, Smyrna, Southern Hills, Murfreesboro, Mt. Juliet, St. Thomas West, Shelbyville, Chattanooga Downtown, Med Park 2, Memorial
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/​6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/​ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer (EvoPAR-BR01)
Condition: Breast Cancer
TO Study: BRE23007
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (DREAMM-20)
Condition: Multiple Myeloma
TO Study: MM24013
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/​ Small Lymphocytic Lymphoma (SLL)
Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
TO Study: CLL23001
Clinic:
Dickson, Franklin, Gallatin, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Mt. Juliet, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) (INTerpath-002)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24037
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
TO Study: GU24006
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
Condition: Colorectal Cancer
TO Study: GI24010
Clinic:
Lebanon, Murfreesboro, Chattanooga Downtown, Med Park 2, Memorial
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/​Refractory Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
TO Study: LYM24022
Clinic:
St. Thomas West, Elliston Place Plaza, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24026
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer (SUNRAY-01)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24032
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator’s Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer (rechARge)
Condition: Prostate Cancer
TO Study: GU24007
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)
Condition: Breast Cancer
TO Study: BRE24013
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Smyrna, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (ALISCA-Breast1)
Condition: Breast Cancer
TO Study: BRE23008
Clinic:
Elliston Place Plaza, Murfreesboro, Mt. Juliet, Shelbyville, Smyrna, Chattanooga Downtown, Med Park 2, Memorial
Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC)
Condition: Breast Cancer
TO Study: BRE 360
Clinic:
Cleveland, Chattanooga Downtown, Med Park 2, Memorial
Phase 2 Open-label Study to Evaluate Momelotinib in Combination with Luspatercept in Participants with Transfusion Dependent Primary or Secondary Myelofibrosis
Condition: Myelofibrosis
TO Study: MPN24004
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Condition: Myelofibrosis
TO Study: MPN24003
Clinic:
Cleveland, Chattanooga Downtown, Med Park 2, Memorial, Dalton, Ringgold, Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Elliston Place Plaza
A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Treatment after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)
Condition: Multiple Myeloma
TO Study: MM 163
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Elliston Place Plaza
Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (CAMMOUFLAGE Trial)
A Phase 1 Study of KTX-1001, an Oral, First-In-Class, Selective, and Potent MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma
Symphony-1: A Phase 1b/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study Of Tazemetostat Or Placebo In Combination With Lenalidomide Plus Rituximab In Subjects With Relapsed/Refractory Follicular Lymphoma
Condition: Follicular Lymphoma
TO Study: LYM 170
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Elliston Place Plaza
A Prospective, Open-Label, Randomized, Phase 3 Trial of Acasunlimab (GEN1046) in Combination With Pembrolizumab Versus Docetaxel in Subjects With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer After Treatment With a PD-1/PD-L1 Inhibitor and Platinum-Containing Chemotherapy…
Condition: Non-small Cell Lung Cancer
TO Study: LUN24030
Clinic:
Gallatin, Mt. Juliet, Murfreesboro, St. Thomas West, Lebanon, Chattanooga Downtown, Med Park 2, Memorial
A Phase 1, Dose Escalation, Safety and Tolerability Study of NX-2127, a Bruton’s Tyrosine Kinase (BTK) Degrader, in Adults with Relapsed/Refractory B-cell Malignancies.
Condition: Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Primary Central Nervous System Lymphoma, Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia
A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
Condition: Large B-Cell Lymphoma
TO Study: LYM24006
Clinic:
Elliston Place Plaza, Chattanooga Downtown, Med Park 2, Memorial
An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Treatment as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-23)
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR – HN1)
Condition: Head and Neck Squamous Cell Carcinoma
TO Study: HN24004
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Mt. Juliet, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared with Investigator’s Choice Monotherapy Treatment in Previously Treated Patients with Incurable, Metastatic/recurrent Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
TO Study: HN23003
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
TO Study: LUN23013
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills
A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants with EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer whose Disease has Progressed on…
Condition: Non-small Cell Lung Cancer
TO Study: LUN24015
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet
A randomized, open-label, phase 3 trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic Non-Small Cell Lung Cancer (NSCLC) and secondary resistance to Immune Checkpoint Inhibitor (ICI)- ARTEMIA…
Condition: Non-small Cell Lung Cancer
TO Study: LUN24016
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Phase III, Randomized, Double-Blind, Multicenter, Global Study of Rilvegostomig in Combination with Chemotherapy for First-line Treatment of Patients with Metastatic Non-squamous Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 (TC ≥ 1%) (ARTEMIDE-Lung03)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24029
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (JADE)
Condition: Head and Neck Squamous Cell Carcinoma
TO Study: HN23002
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Phase I/II Open-Label Multi-Center Study to Characterize the Safety and Tolerability of CFT7455 in Subjects with Relapsed/Refractory Non-Hodgkin’s Lymphoma or Multiple Myeloma
A Study of Amivantamab and FOLFIRI Versus Cetuximab/​Bevacizumab and FOLFIRI in Participants With KRAS/​NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy (OrigAMI-3)
Condition: Colorectal Cancer
TO Study: GI24012
Clinic:
Elliston Place Plaza, Murfreesboro, Smyrna, Chattanooga Downtown, Med Park 2, Memorial
First-in-Human, Open-Label, Phase 1/2 Dose-Escalation with Enrichment and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GIM-122 as a Single Agent in Adult Subjects with Advanced Solid Malignancies
Phase 1/2, Open-label, Multi-center Study of the Safety, Tolerability, and Efficacy of GIM-531 as a Single Agent and in Combination with Anti-PD-1 in Advanced Solid Tumors
A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer…
Condition: Breast Cancer
TO Study: BRE24011
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville
A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive…
Condition: Breast Cancer
TO Study: BRE23006
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
